FDA greenlights Amylyx’s ALS drug

September 29 (Reuters) – Amylyx Pharmaceuticals Inc. (AMLX.O) said on Thursday that the US Food and Drug Administration approved its drug to slow the progression of ALS, or amyotrophic lateral sclerosis, and potentially delay death, sending the company’s shares up almost 14 % on extended trading. The company added that healthcare professionals will soon be … Read more

Column: Oil and coal sectors think more fossil fuels is the solution. Probably not: Russell

LAUNCESTON, Australia, September 29 – If there’s one thing the oil and coal industries can agree on, it’s that the solution to the current global energy crisis is more fossil fuels. This was the consistent message from the biggest annual meetings of the two industries in Asia, held this week in Singapore for oil and … Read more

China property shares, bonds slump as CIFI default report adds to sector woes

SHANGHAI, Sept 28 (Reuters) – Investors dumped shares and bonds of Chinese property developers on Wednesday, after a media report that CIFI Holdings (Group) Co had defaulted added to concerns about the real estate sector affected by the crisis. Hong Kong-listed shares of CIFI Holdings (0884.HK)It fell 32.3% to a record low at the close … Read more

Analysis: Alzheimer’s drug trial breakthrough boost for Roche, Eli Lilly

Biogen and Eisai report a landmark result for an experimental drug Almost all Alzheimer’s trials have previously failed Roche and Eli Lilly drugs target the same protein as Eisai’s compound Biogen Stocks of all four drugmakers soar on news LONDON, Sept 28 (Reuters) – The results of a key trial of an Alzheimer’s drug on … Read more

In China, home buyers occupy their ‘rotting’, unfinished properties

GUILIN, China, Sept 26 (Reuters) – For six months, Xu’s home has been a room in a high-rise apartment in the southern Chinese city of Guilin, which she bought three years ago, lured by brochures. that promoted their views of the river. and the clean air of the city. Their living conditions, however, are far … Read more

Novartis to prioritise U.S. market, unfazed by drug pricing pushback

The logo of Swiss pharmaceutical company Novartis is seen at the company’s plant in the northern Swiss town of Stein October 23, 2017. REUTERS/Arnd Wiegmann/File photo Sign up now for FREE unlimited access to Reuters.com Record ZURICH, Sept 22 (Reuters) – Swiss pharmaceutical giant Novartis (NOVN.S) he said he would make growth in the United … Read more

U.S. home sales drop for 7th straight month, house price growth cooling

Existing home sales fall 0.4% in August The average price of housing increases by 7.7% compared to the previous year Housing supply at 1.28 million, unchanged from a year ago WASHINGTON, Sept 21 (Reuters) – U.S. existing home sales fell for the seventh straight month in August as affordability deteriorated further amid rising mortgage rates … Read more

Investors mixed as Porsche seeks price tag of up to $75 bln

Sign up now for FREE unlimited access to Reuters.com Record Volkswagen shares little changed, Porsche SE up 3.5% Porsche AG will be listed at a valuation of 70-75 billion euros The listing comes amid turmoil in European markets Cornerstone investors pledged 40% of share offering BERLIN, Sept 19 (Reuters) – Shares of Volkswagen (VOWG_p.DE) hovered … Read more

Some investors fear Fed will tighten rates too far as inflation bites

The Federal Reserve Board building on Constitution Avenue is pictured in Washington, U.S., March 27, 2019. REUTERS/Brendan McDermid/File photo Sign up now for FREE unlimited access to Reuters.com Record Sept 19 (Reuters) – Just a few months ago, investors worried that the Federal Reserve was not fighting inflation aggressively enough. After several giant rate hikes, … Read more

Analysis: Price hikes test Inditex’s ability to stay in fashion

Sign up now for FREE unlimited access to Reuters.com Record Initial prices at Zara rise 12.2% in the year to July: UBS Inditex says it will raise prices again in the second half Analysts urge caution amid signs of slowing apparel demand MADRID, Sept 15 (Reuters) – Zara owner Inditex’s strong first half results show … Read more